Details of the Metabolic Reaction (MR)
General Information of This Metabolic Reaction (MR) (ID: MR013395) | ||||||
---|---|---|---|---|---|---|
Formula | Reactant | Metoclopramide hydrochloride | Product | Metoclopramide hydrochloride Metabolite M4 | ||
Reactant Info | Product Info | |||||
Metabolic Enzyme | Cytochrome P450 2D6 (CYP2D6) | DME Info | ||||
Cytochrome P450 1A2 (CYP1A2) | DME Info | |||||
Cytochrome P450 3A4 (CYP3A4) | DME Info | |||||
Cytochrome P450 2C9 (CYP2C9) | DME Info | |||||
Mephenytoin 4-hydroxylase (CYP2C19) | DME Info | |||||
Metabolic Type | Oxidation - Oxidationn | |||||
Other MR(s) Related to The Product of This MR | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other MR(s) That Metabolize The Produtc of This MR | |||||||||||||||||||||||||||||
|
References | ||||||
---|---|---|---|---|---|---|
1 | Clinical pharmacokinetics of metoclopramide | |||||
2 | Metoclopramide is metabolized by CYP2D6 and is a reversible inhibitor, but not inactivator, of CYP2D6. Xenobiotica. 2014 Apr;44(4):309-319. | |||||
3 | Identification of novel metoclopramide metabolites in humans: in vitro and in vivo studies | |||||
4 | The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6. Drug Metab Dispos. 2002 Mar;30(3):336-43. | |||||
5 | Lessons from pharmacogenetics and metoclopramide: toward the right dose of the right drug for the right patient. J Clin Gastroenterol. 2012 Jul;46(6):437-9. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.